Compounded Tirzepatide Medication Information
Safety information for compounded tirzepatide injection.
What it is
Tirzepatide acts on GIP and GLP-1 pathways and may be prescribed as part of a clinician-supervised weight care plan when appropriate. The compounded form offered through Cuora Health, if prescribed, is prepared by [[PHARMACY_LEGAL_NAME - client to supply]], a state-licensed compounding pharmacy. Compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality before dispensing. A compounded medication is not equivalent to any brand-name product, even when it contains the same active ingredient.
Who should not use it
Do not use tirzepatide if you or a family member has had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, if you have had a serious allergic reaction to tirzepatide or any ingredient in the medication, or if you are pregnant, breastfeeding, trying to become pregnant, or not using appropriate contraception as directed by your clinician. Tell your clinician about pancreatitis, gallbladder disease, kidney problems, diabetes medicines, digestive disease, mental health history, surgeries, and all medications and supplements.
Boxed-warning subject matter
Tirzepatide carries boxed-warning subject matter about thyroid C-cell tumors observed in rodent studies. It is not known whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans. Report a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath to a healthcare professional.
Common side effects
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, reduced appetite, fatigue, dizziness, burping, hair shedding during weight loss, and injection site reactions. Your clinician selects and adjusts your dose based on your history, response, and tolerability.
Serious side effects
Seek immediate medical care for severe or persistent abdominal pain, pain that may spread to the back, repeated vomiting, signs of dehydration, fainting, trouble breathing, swelling of the face or throat, hives, chest pain, sudden vision changes, yellowing of the skin or eyes, severe mood or behavior changes, or any symptom that feels urgent. Serious risks may include pancreatitis, gallbladder problems, kidney injury, severe allergic reactions, severe gastrointestinal disease, and low blood sugar when used with insulin or sulfonylureas.
Storage and handling
Follow the storage instructions included with your medication and the directions from the pharmacy. Some tirzepatide preparations may require refrigeration and protection from excessive heat or light. Do not use medication that is expired, cloudy when it should be clear, discolored, leaking, damaged, contaminated, or stored outside pharmacy instructions. Keep medication and supplies away from children and pets, and dispose of needles in an approved sharps container.
Missed dose
If you miss a dose, follow the instructions provided by your clinician or pharmacy. Do not take extra medication or change your schedule without clinical guidance. Contact your clinician or pharmacy if you are unsure what to do.
Last reviewed: [[LEGAL_REVIEW_DATE - client to supply]]
View combined safety information